Navigation Links
Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift
Date:10/28/2008

WASHINGTON, D.C. (October 28, 2008) Scientists at NanoBio Corporation have demonstrated for the first time in humans that a novel topical treatment for cold sores (herpes labialis), NB-001, speeds healing of lesions as effectively as the leading oral systemic drugs but without safety or toxicity concerns.

The new data provide the first proof of principle that a topical agent can attain equivalent efficacy rates to oral systemic drugs, according to the NanoBio scientists. Topical treatments are widely considered inferior to oral systemic treatments because they fail to penetrate to the site of infection with adequate drug levels required to subdue infections.

In the study of 482 patients, NB-001 healed lesions 1.3 days faster than placebo as measured by investigators (P=0.006). Results of the randomized, double-blind, placebo-controlled, phase 2b trial are being presented at the 48th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th annual meeting in Washington, D.C.

NB-001 was well tolerated, without safety concerns or adverse events, and was not systemically absorbed. "NB-001 challenges the conventional wisdom that topical therapies are less effective, because NB-001 directly accesses the site of infection in the dermis and epidermis instead of remaining on top of the skin," said James R. Baker, Jr., M.D., founder and chairman of NanoBio Corp. "NB-001 employs a physical mode of action to disrupt the outer membranes of pathogens and prompt viral lysis, essentially killing on contact."

The study also suggests that the physical mode of action of NB-001 significantly reduces the likelihood that pathogens will develop resistance to the biocidal effect of the topical lotion.

"These characteristics make NB-001 an ideal candidate for first-line treatment with the potential for widespread use across a broad range of patients," said Mary Fla
'/>"/>

Contact: Becky Levine
blevine@medthink.com
919-786-4918
MedThink Communications
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
2. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
3. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
4. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
5. Topical treatment for age spots, from Harvard Womens Health Watch
6. Summit VetPharm Introduces New Feline Topicals Vectra(TM) for Cats & Kittens and Vectra(TM) for Cats
7. International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream
8. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
9. Topical Cream Treats Precancerous Lesions of Vulva
10. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
11. Fougera First-to-Market With Calcipotriene Topical Solution 0.005% (Rx) (Scalp Solution)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... will allow them to take pressure measurements in patients’ ... function. The doctor usually orders it if they have ... bladder (OAB). , Women’s Excellence in Bladder ... problems with unwanted urinary leakage or problems with overall ...
(Date:5/24/2015)... Indiana (PRWEB) May 24, 2015 Indiana ... service provider announces Midwest Telecom of America, Inc. (MTA) ... , According to Cory Childs, IFN Enterprise Sales Manager, ... service providers. “IFN’s fiber transport provides MTA with ... Center to their Tier 1 Internet and voice carriers ...
(Date:5/23/2015)... On May 13, Nithyananda Yoga Foundation organized a ... learned through meditation and initiation at Special Holistic School ... Yogamaatha, a nine-year-old girl from North Carolina, stunned an ... the 2015 Business Advocacy Summit at Capitol Hill in ... In a demonstration that lasted three hours, Yogamaatha was ...
(Date:5/23/2015)... May 23, 2015 Manufacturers are now required ... Factor (HSPF) of 8.2. Experts in the field agree that ... consumers. , The HSPF score is what miles per gallon ... efficient the unit. Although the minimum HSPF score has been ... with an HSPF score north of 12. Indeed, the regulation ...
(Date:5/22/2015)... 2015 The world is at ... are intersecting to create new opportunities for leadership ... speaker at WesternU's 34th annual Commencement Exercises said ... Newsom, a former San Francisco mayor and likely ... the graduation ceremony for WesternU's colleges of Allied ...
Breaking Medicine News(10 mins):Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3
... can quickly become a potent cancer promoter in adult mice ... Cancer Center, causing white blood cells to become cancerous spontaneously. ... Research, the researchers detail how a gene called Dlx5 works ... mice. The protein that Dlx5 encodes could be a target ...
... Take Charge of Your Health - A Self-Care Initiative and the ... ... 27 Blue Cross of,California,s Self-Care Initiative and Member Health Index ... Cross and Blue Shield,Association, BlueWorks recognizes the innovative ways Blue Cross ...
... Acuitec,s Vigilance has been,awarded the 2008 ... for Clinical Records -- Inpatient. The Vigilance ... Anesthesia at Vanderbilt University,Medical Center, enables clinicians ... the physician to customize built-in,intelligent alerts based ...
... 1950s for causing birth defects, is now showing promise ... recurrent ovarian cancer, according to a study led by ... Jr., M.D., principal investigator for the multicenter, randomized Phase ... research study in the current issue of the journal ...
... of dollars spent on food safety research over the last ... were higher in 2007 than in 2006, according to researchers ... coli O157:H7 has been linked to foodborne illnesses in humans ... studying the effects of a novel vaccine technology to make ...
... be encouraged to get inoculated , , WEDNESDAY, Feb. 27 ... all children 6 months to 18 years of age ... that children 6 months to 5 years of age ... Centers for Disease Control and Prevention,s Advisory Committee on ...
Cached Medicine News:Health News:Inverted DNA turns quiet developmental gene into a potent driver of t-cell lymphoma 2Health News:Blue Cross of California Honored with Two BlueWorks(R) Awards 2Health News:Blue Cross of California Honored with Two BlueWorks(R) Awards 3Health News:Blue Cross of California Honored with Two BlueWorks(R) Awards 4Health News:Acuitec's Vigilance Product Wins Microsoft Award as Most Innovative Product for 2008 2Health News:U of Minnesota study finds thalidomide shows promise for treatment of recurrent ovarian cancer 2Health News:Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle 2Health News:CDC Panel Urges Extending Flu Vaccine Coverage for Kids 2Health News:CDC Panel Urges Extending Flu Vaccine Coverage for Kids 3
(Date:5/22/2015)... TORONTO , May 22 2015 /CNW/ - The Taskforce ... are very appreciative of all the hard work that the ... the past six months. This program recognizes the needs of ... receive at least $75,000 a year, tax free, with annual ... will be eligible for annual payments of $100,000 based on ...
(Date:5/22/2015)... BOTHELL, Wash. , May 22, 2015  BioLife Solutions, ... marketer of proprietary clinical grade hypothermic storage and ... products for cells and tissues ("BioLife" or the "Company"), ... 2015 Marcum MicroCap Conference. The Company is ... on Wednesday, May 27, 2015 at the Grand Hyatt Hotel ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... protection, repair and regeneration, today announced that J.J. ... to present a corporate overview at two upcoming investor ... the SeeThruEquity 4 th Annual Microcap Conference on ... City at 11:00 am EDT.  A webcast ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... BOTHELL, Wash., Jan. 8 Nastech Pharmaceutical,Company Inc. ... enrollment for its,Phase 2 clinical trial of PYY3-36 ... obese patients at multiple clinical sites in the ... study. The,study is designed to evaluate three different ...
... Logix today announced positive,results in the Company,s Phase ... double-blind, placebo-controlled crossover,Phase 2a study in 60 patients ... reductions in blood pressure,and was well tolerated. The ... effect on blood pressure in patients of repeat ...
Cached Medicine Technology:Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity 2Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity 3Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension 2Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension 3
... can choose either the PARI LC PLUS® or ... to both:, ,Maximize aerosol output when the ... patient exhales using two one-way valves. Baffles allow ... The result is a high percentage of particles ...
... with metered dose inhalers., ,ACE ensures ... MDI canisters. Its versatile design allows it ... in conjunction with an endotracheal airway or ... ACE may also be used in conjunction ...
... Kit Nebulizer Small Volume Medication W/Adult Mask ... Tubing Tee Adapter , ,An ... , ,Provide fine particles with a ... than conventional nebulizers, ,Our AirLife™ brand ...
... Products, ,Westmed designs, manufacturers and markets ... Respiratory professionals. Our mission is to design ... ability to deliver quality medical care while ... , ,Our web site is designed ...
Medicine Products: